Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

The prevalence of atrial fibrillation, also known as AFIB, affects a lot more younger people than initially thought.

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost doubled – the cure rate for patients with the most common kind of ...

A new report has found that cancer patients living in poorer areas of England are up to a third more likely to wait over 104 ...

In a 15-year prospective follow-up study of more than 400 patients with relapsed APL, oral-ATO-based treatment resulted in a 100% molecular remission rate and a five-year OS rate of 80%.

Hutto City Council approved a contract to conduct a utility rate study at its Feb. 20 meeting. The city last reviewed water ...

The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...